Journal
NATURE REVIEWS NEPHROLOGY
Volume 11, Issue 2, Pages 68-69Publisher
NATURE PUBLISHING GROUP
DOI: 10.1038/nrneph.2014.238
Keywords
-
Categories
Ask authors/readers for more resources
In 2014, key studies in the field of diabetic nephropathy highlighted the importance of albuminuria as a predictor of cardiovascular risk and showed that the incidence of renal and cardiovascular complications is decreasing. Promising efficacy data were obtained with atrasentan, whereas a trial of bardoxolone methyl led to safety concerns.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
